Healthcare Industry News:  Merit Medical Systems 

Devices FDA

 News Release - January 24, 2006

Merit Medical Receives FDA Clearance for Impress(TM) Catheter

SOUTH JORDAN, Utah--(HSMN NewsFeed)--Jan. 24, 2006--Merit Medical Systems Inc. (NASDAQ: MMSI ), a manufacturer and marketer of proprietary disposable accessories used primarily in cardiology and radiology procedures, today announced that it received FDA clearance to market its new Impress(TM) catheter.

The Merit Impress(TM) is a new line of diagnostic, peripheral catheters that provide clinicians with several new features. The new accordion design, insert-molded hub and strain relief minimize kinking and provide improved steering capability with wet, gloved hands. High repeatability of braid pattern provides premier flexibility without compromising steerability. The tapered tip is designed to seek the ostium of the vessel and is highly visible under fluoroscopy. The fourth of Merit's magnificent seven new products, the Impress(TM) has excellent tip memory and is available in a variety of tip shapes.

"The Impress(TM) catheter provides clinicians with an improved peripheral catheter for diagnosis," said Fred P. Lampropoulos, Merit's chairman and CEO. "It is another example of Merit's commitment to improving and enhancing our existing catheter line."

About Merit

Founded in 1987, Merit Medical Systems Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical accessories used in interventional and diagnostic procedures, particularly in cardiology and radiology. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 85 individuals. Merit employs approximately 1,560 people worldwide, with facilities in Salt Lake City and South Jordan, Utah; Santa Clara, Calif.; Angleton, Texas; Richmond, Va.; Jackson, N.J.; Maastricht, Netherlands; and Galway, Ireland.

Statements contained in this release which are not purely historical are forward-looking statements within the meaning of the Private Securities Litigation Act of 1995 and are subject to risks and uncertainties such as those described in Merit's Annual Report on Form 10-K for the year ended Dec. 31, 2004. Such risks and uncertainties include market acceptance of new products, introduction of products in a timely fashion, product recalls, delays in obtaining regulatory approvals, or the failure to maintain such approvals, cost increases, fluctuations in and obsolescence of inventory, price and product competition, availability of labor and materials, development of new products and technology that could render our products obsolete, product liability claims, modification or limitation of governmental or private insurance reimbursement, infringement of our technology or the assertion that our technology infringes the rights of other parties, foreign currency fluctuations, challenges associated with the company's growth strategy, changes in health care markets related to health care reform initiatives, litigation and other factors referred to in the company's 10-K and other reports filed with the Securities and Exchange Commission. All subsequent forward-looking statements attributable to the company or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Actual results may differ materially from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results, and Merit assumes no obligation to update or disclose revisions to those estimates.


Source: Merit Medical Systems

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.